12:00 AM
Feb 04, 2013
 |  BC Week In Review  |  Financial News  |  Completed Offerings

Ventrus Biosciences completes follow-on

Ventrus Biosciences Inc. (NASDAQ:VTUS), New York, N.Y.
Business: Gastrointestinal, Genitourinary

Read the full 34 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >